Hepatitis C Drugs Multiply Effect of COVID-19 Antiviral Remdesivir

Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://news.utexas.edu/2021/04/27/hepatitis-c-drugs-boost-remdesivirs-antiviral-activity-against-covid-19/
Research Institution
The University of Texas at Austin
Short Title
Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck

How SARS-CoV-2 Hijacks Human Cells to Evade Immune System

Using Nanobodies to Block a Tick-Borne Bacterial Infection

New Cell Atlas of COVID Lungs Reveals Why SARS-CoV-2 Is Deadly and Different

Getting to the Core of HIV Replication

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.tacc.utexas.edu/-/getting-to-the-core-of-hiv-replication
Research Institution
The University of Texas at Austin
Short Title
Getting to the Core of HIV Replication
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck

B.1.1.7 Variant of COVID-19 Virus Spreading Rapidly in United States

Scientists Identify Virus-Cell Interaction that May Explain COVID-19’s High Infection Rate

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www2.lehigh.edu/news/scientists-identify-virus-cell-interaction-that-may-explain-covid-19s-high-infection-rate
Research Institution
Lehigh University
Short Title
Scientists Identify Virus-Cell Interaction that May Explain COVID-19’s High Infection Rate
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck

Exploring Variations in Herpes Virus Symptoms

Diabetes Drug May Be a New Weapon Against HIV

Subscribe to